Personalis (PSNL) Projected to Post Quarterly Earnings on Thursday

Personalis (NASDAQ:PSNL) is projected to release its earnings data after the market closes on Thursday, February 27th. Analysts expect Personalis to post earnings of ($0.32) per share and revenue of $15.48 million for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

Personalis Stock Down 7.4 %

PSNL stock opened at $4.23 on Wednesday. Personalis has a 52-week low of $1.13 and a 52-week high of $7.20. The stock’s fifty day simple moving average is $5.43 and its 200-day simple moving average is $5.05. The stock has a market capitalization of $298.84 million, a price-to-earnings ratio of -2.52 and a beta of 1.73.

Analyst Upgrades and Downgrades

PSNL has been the topic of a number of recent research reports. Lake Street Capital boosted their price objective on Personalis from $7.00 to $9.00 and gave the stock a “buy” rating in a research note on Wednesday, January 8th. Needham & Company LLC reaffirmed a “buy” rating and set a $7.25 target price on shares of Personalis in a research report on Wednesday, January 8th. Finally, HC Wainwright lowered their price objective on Personalis from $11.00 to $8.00 and set a “buy” rating for the company in a report on Monday, January 27th.

About Personalis

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.